DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr |
What is the latest Consolidated Net Profit of DIVIS LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹2,191 Cr |
Mar2024 | ₹1,600 Cr |
Mar2023 | ₹1,824 Cr |
Mar2022 | ₹2,960 Cr |
Mar2021 | ₹1,984 Cr |
How is Consolidated Net Profit of DIVIS LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹2,191 Cr | 36.94 | |
Mar2024 | ₹1,600 Cr | -12.28 | |
Mar2023 | ₹1,824 Cr | -38.39 | |
Mar2022 | ₹2,960 Cr | 49.19 | |
Mar2021 | ₹1,984 Cr | - |
Compare Consolidated Net Profit of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹164,574.2 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics | |
MANKIND PHARMA | ₹109,835.0 Cr | 3% | 6.2% | 7.5% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 2.4% |
3.2% |
11.9% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses